Artelo Biosciences Balance Sheet (2014-2025)

Reported Financials

Artelo Biosciences Quarterly Balance Sheet

Periods 47 quarters

Latest Dec 2025

Artelo Biosciences reported total assets of $2.80M and total liabilities of $4.07M for the quarter ended Dec 2025, down 40.4% year over year. This balance sheet covers 47 quarters of results from May 2014 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Feb2021	May2021	Aug2021	Nov2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	10.71M	10.05M	6.63M	14.05M	10.35M	12.12M	7.14M	6.89M	6.92M	5.72M	2.64M	2.81M	1.20M	0.88M	4.36M	2.34M	0.75M	2.07M	1.72M	0.60M
Short-term InvestmentsInvestments (Current)	0.51M		3.44M	12.32M	2.00M	1.99M	1.49M	9.15M	8.57M	8.27M	10.22M	7.61M	6.41M	4.72M	0.50M
Cash & Current Investments	11.22M	10.05M	10.06M	26.36M	12.35M	14.11M	8.62M	16.04M	15.48M	13.99M	12.86M	10.43M	7.61M	5.60M	4.86M	2.34M	0.75M	2.07M	1.72M	0.60M
Receivables - OtherOther Receivables
Prepaid Assets	0.19M	0.18M	0.25M	0.51M	1.08M	0.83M	0.69M	0.79M	0.90M	0.61M	0.56M	0.55M	0.58M	0.57M	0.13M	0.22M	0.21M	0.17M	0.11M	0.10M
Current Assets	11.41M	10.30M	10.32M	25.36M	24.59M	22.28M	20.30M	18.32M	16.39M	14.60M	13.43M	10.98M	8.19M	6.17M	4.99M	2.56M	1.38M	2.23M	1.83M	0.69M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	124.00	63.00
Long-Term Investments			3.44M	1.52M				9.15M	8.57M	8.27M	10.22M	7.61M		2.23M	0.50M
Intangibles	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M
Goodwill & Intangibles	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M
Other Non-Current Assets		0.07M	0.19M			0.13M	0.00M	0.00M	0.00M	0.20M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.42M	0.00M	0.25M	0.00M
Non-Current Assets	2.04M	2.04M	2.32M	3.65M	2.12M	2.12M	2.11M	2.10M	2.09M	2.27M	2.07M	2.06M	2.17M	2.16M	2.15M	2.14M	2.13M	2.12M	2.44M	2.11M
Assets	13.44M	12.34M	12.63M	29.00M	26.70M	24.41M	22.41M	20.42M	18.48M	16.88M	15.50M	13.04M	10.35M	8.33M	7.14M	4.70M	3.52M	4.36M	4.27M	2.80M
Liabilities
Current Liabilities
Accounts Payables			0.47M	0.59M	0.80M	0.43M	0.41M	0.91M	0.70M	0.52M	0.84M	1.24M	0.61M	0.86M	0.63M	1.68M	2.51M	4.84M	3.87M	3.04M
Notes Payables	0.01M	0.01M	0.03M	0.04M	0.04M	0.05M	0.03M	0.05M	0.09M										0.88M	0.44M
Payables	0.01M	0.01M	0.50M	0.63M	0.84M	0.48M	0.44M	0.96M	0.79M	0.52M	0.84M	1.24M	0.61M	0.86M	0.63M	1.68M	2.51M	4.84M	4.74M	3.47M
Accumulated Expenses	0.58M	0.42M																0.02M	0.05M	0.01M
Current Leases			0.03M	0.03M	0.03M	0.04M	0.04M	0.04M	0.04M	0.03M	0.03M	0.02M	0.03M	0.03M	0.03M	0.04M	0.04M	0.04M	0.04M	0.04M
Total Current Liabilities	0.59M	0.42M	0.53M	0.66M	0.88M	0.53M	0.48M	1.00M	0.82M	0.60M	0.92M	1.29M	0.72M	0.94M	0.70M	1.77M	2.80M	5.71M	4.86M	4.04M
Non-Current Liabilities
Convertible Debt																		0.79M	0.88M	0.61M
Operating Leases			0.07M	0.06M	0.05M	0.04M	0.03M	0.02M	0.01M	0.01M			0.10M	0.09M	0.08M	0.07M	0.06M	0.05M	0.04M	0.03M
Total Liabilities	0.59M	0.42M	0.59M	0.72M	0.92M	0.57M	0.51M	1.02M	0.84M	0.61M	0.92M	1.29M	0.82M	1.03M	0.78M	1.84M	2.86M	5.76M	4.90M	4.07M
Shareholder's Equity
Total Debt	0.01M	0.01M	0.03M	0.04M	0.04M	0.05M	0.03M	0.05M	0.09M										0.88M	0.44M
Common Equity	12.86M	11.92M	12.04M	28.29M	25.78M	23.84M	21.90M	19.40M	17.64M	16.27M	14.58M	11.75M	9.54M	7.30M	6.36M	2.86M	0.65M	-1.41M	-0.63M	166.67M
Liabilities and Shareholders Equity	13.44M	12.34M	12.63M	29.00M	26.70M	24.41M	22.41M	20.42M	18.48M	16.88M	15.50M	13.04M	10.35M	8.33M	7.14M	4.70M	3.52M	4.36M	4.27M	2.80M
Retained Earnings	25.55M	26.86M	28.93M	47.72M	48.70M	49.32M	49.97M	50.67M	51.03M	51.25M	52.01M	52.26M	52.53M	52.73M	52.93M	53.19M	53.38M	-55.73M	-58.85M	-63.02M
Preferred Shares																				0.02M

Artelo Biosciences ARTL Balance Sheet (2014-2025)

Artelo Biosciences Quarterly Balance Sheet

Create an account

Sign In

Reset Password